377 related articles for article (PubMed ID: 33054518)
1. Butyrate mediates anti-inflammatory effects of
Lenoir M; Martín R; Torres-Maravilla E; Chadi S; González-Dávila P; Sokol H; Langella P; Chain F; Bermúdez-Humarán LG
Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 33054518
[TBL] [Abstract][Full Text] [Related]
2. Barrier Protection and Recovery Effects of Gut Commensal Bacteria on Differentiated Intestinal Epithelial Cells In Vitro.
Mohebali N; Ekat K; Kreikemeyer B; Breitrück A
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32731411
[TBL] [Abstract][Full Text] [Related]
3. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
[TBL] [Abstract][Full Text] [Related]
4.
Wang X; Li Y; Wang X; Wang R; Hao Y; Ren F; Wang P; Fang B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674791
[TBL] [Abstract][Full Text] [Related]
5. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
[TBL] [Abstract][Full Text] [Related]
6. Inulin-grown
Fagundes RR; Bourgonje AR; Saeed A; Vich Vila A; Plomp N; Blokzijl T; Sadaghian Sadabad M; von Martels JZH; van Leeuwen SS; Weersma RK; Dijkstra G; Harmsen HJM; Faber KN
Gut Microbes; 2021; 13(1):1993582. PubMed ID: 34793284
[TBL] [Abstract][Full Text] [Related]
7. Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3.
Zhang M; Zhou L; Wang Y; Dorfman RG; Tang D; Xu L; Pan Y; Zhou Q; Li Y; Yin Y; Zhao S; Wu J; Yu C
Int Immunol; 2019 Jul; 31(8):499-514. PubMed ID: 30809639
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
[TBL] [Abstract][Full Text] [Related]
9. Expression of CCR6 and CXCR6 by Gut-Derived CD4
Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
[TBL] [Abstract][Full Text] [Related]
10. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.
Miquel S; Leclerc M; Martin R; Chain F; Lenoir M; Raguideau S; Hudault S; Bridonneau C; Northen T; Bowen B; Bermúdez-Humarán LG; Sokol H; Thomas M; Langella P
mBio; 2015 Apr; 6(2):. PubMed ID: 25900655
[TBL] [Abstract][Full Text] [Related]
11. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P
Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134
[TBL] [Abstract][Full Text] [Related]
12. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent.
Wrzosek L; Miquel S; Noordine ML; Bouet S; Joncquel Chevalier-Curt M; Robert V; Philippe C; Bridonneau C; Cherbuy C; Robbe-Masselot C; Langella P; Thomas M
BMC Biol; 2013 May; 11():61. PubMed ID: 23692866
[TBL] [Abstract][Full Text] [Related]
13. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.
Miquel S; Martín R; Lashermes A; Gillet M; Meleine M; Gelot A; Eschalier A; Ardid D; Bermúdez-Humarán LG; Sokol H; Thomas M; Theodorou V; Langella P; Carvalho FA
Sci Rep; 2016 Jan; 6():19399. PubMed ID: 26775847
[TBL] [Abstract][Full Text] [Related]
14. Induction effects of Faecalibacterium prausnitzii and its extracellular vesicles on toll-like receptor signaling pathway gene expression and cytokine level in human intestinal epithelial cells.
Rabiei N; Ahmadi Badi S; Ettehad Marvasti F; Nejad Sattari T; Vaziri F; Siadat SD
Cytokine; 2019 Sep; 121():154718. PubMed ID: 31153056
[TBL] [Abstract][Full Text] [Related]
15. Action and function of Faecalibacterium prausnitzii in health and disease.
Ferreira-Halder CV; Faria AVS; Andrade SS
Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):643-648. PubMed ID: 29566907
[TBL] [Abstract][Full Text] [Related]
16. Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive
Zhang J; Huang YJ; Yoon JY; Kemmitt J; Wright C; Schneider K; Sphabmixay P; Hernandez-Gordillo V; Holcomb SJ; Bhushan B; Rohatgi G; Benton K; Carpenter D; Kester JC; Eng G; Breault DT; Yilmaz O; Taketani M; Voigt CA; Carrier RL; Trumper DL; Griffith LG
Med; 2021 Jan; 2(1):74-98.e9. PubMed ID: 33511375
[TBL] [Abstract][Full Text] [Related]
17. Administration of live, but not inactivated, Faecalibacterium prausnitzii has a preventive effect on dextran sodium sulfate‑induced colitis in mice.
Kawade Y; Sakai M; Okamori M; Morita M; Mizushima K; Ueda T; Takagi T; Naito Y; Itoh Y; Shimada T
Mol Med Rep; 2019 Jul; 20(1):25-32. PubMed ID: 31115531
[TBL] [Abstract][Full Text] [Related]
18. Co-Culture with
Kim H; Jeong Y; Kang S; You HJ; Ji GE
Microorganisms; 2020 May; 8(5):. PubMed ID: 32466189
[No Abstract] [Full Text] [Related]
19. Alterations in the Abundance and Co-occurrence of
Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
[No Abstract] [Full Text] [Related]
20. Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure.
Roychowdhury S; Cadnum J; Glueck B; Obrenovich M; Donskey C; Cresci GAM
JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1156-1167. PubMed ID: 29385239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
